Juva Life Inc.
JUVAF
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 154.25% | -18.21% | 49.14% | 15.83% | 4.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 154.25% | -18.21% | 49.14% | 15.83% | 4.69% |
| Cost of Revenue | 63.58% | -31.74% | 59.67% | 125.49% | 68.24% |
| Gross Profit | 26,885.71% | 259.78% | 6.52% | -148.32% | -100.94% |
| SG&A Expenses | -4.79% | -46.50% | -49.63% | -48.45% | -17.70% |
| Depreciation & Amortization | -64.78% | -35.76% | -1.22% | -125.05% | 168.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.47% | -38.67% | -20.81% | 0.92% | 17.43% |
| Operating Income | 69.35% | 54.45% | 49.72% | 11.89% | -25.26% |
| Income Before Tax | 75.80% | 4.53% | 51.78% | -67.93% | -84.23% |
| Income Tax Expenses | 114.22% | 183.97% | -94.46% | 0.54% | 203.75% |
| Earnings from Continuing Operations | 73.09% | 0.93% | 52.16% | -68.76% | -91.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.09% | 0.93% | 52.16% | -68.76% | -91.83% |
| EBIT | 69.35% | 54.45% | 49.72% | 11.89% | -25.26% |
| EBITDA | 76.41% | 59.75% | 55.78% | 24.44% | -13.33% |
| EPS Basic | 72.88% | 0.85% | 54.12% | -62.89% | -92.39% |
| Normalized Basic EPS | 75.23% | 55.00% | 53.33% | -50.79% | -84.75% |
| EPS Diluted | 72.88% | 0.85% | 54.12% | -62.89% | -92.39% |
| Normalized Diluted EPS | 75.23% | 55.00% | 53.33% | -50.79% | -84.75% |
| Average Basic Shares Outstanding | 0.03% | 0.12% | 4.02% | 4.02% | 0.09% |
| Average Diluted Shares Outstanding | 0.03% | 0.12% | 4.02% | 4.02% | 0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |